ArQule, Inc. (ARQL) Stock: Seeing Gains In Today’s Session


ArQule, Inc. (ARQL) is trending up in the market in today’s trading session. The company, focused in the biotech industry, is currently trading at $5.90 after gaining 6.12% so far in today’s session. As it relates to biotech companies, there are a number of aspects that have the potential to cause price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the recent trending headlines relating to ARQL:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-11-19 08:39AM Do Options Traders Know Something About ArQule (ARQL) Stock We Don’t?
Apr-02-19 07:00AM ArQule to Present at 18th Annual Needham Healthcare Conference on April 9, 2019
Mar-15-19 07:00AM ArQule Announces Management Team Changes
Mar-13-19 09:52AM Edited Transcript of ARQL earnings conference call or presentation 7-Mar-19 2:00pm GMT
07:00AM ArQule to Present at Oppenheimers 29th Annual Healthcare Conference on March 20, 2019

Nonetheless, when making an investing decision, prospective investors should take a look at far more than news, especially in the speculative biotech industry. Here’s what’s happening with ArQule, Inc..

Recent Trends From ARQL

While a gain in a single session, like the gain that we’re seeing from ArQule, Inc. may cause excitement in some investors, a single session move by itself shouldn’t be the basis of a decision to, or not to, invest in a stock. It’s generally smart to look into trends experienced by the stock further out than a single session. As it relates to ARQL, here are the movements that investors have experienced:

  • Past Seven Days – Throughout the past 7 days, ARQL has generated a change in value amounting to 15.46%.
  • Monthly – The monthly performance from ArQule, Inc. comes to 26.07%.
  • Past Three Months – In the past three months, the stock has generated a return on investment of 67.14%
  • Bi-Annually – Over the past 6 months, we have seen a change that works out to 33.79% from the stock.
  • YTD – Since the the last trading session of last year ARQL has generated a return on investment of 113.00%.
  • Full Year – Finally, over the past full year, investors have seen a change in the amount of 111.47% from ARQL. Throughout this period, the stock has sold at a high of -18.17% and a low of 164.57%.

Important Ratios

Digging into a few ratios having to do with a company generally gives traders a look of just how risky and/or rewarding a an investment option might be. Below are some of the key ratios to consider when looking at ARQL.

Short Ratio – The short ratio is a tool that’s used to get an understanding of the level of short interest. The higher this short ratio, the more investors are expecting that the price of the stock is going to tumble. Throughout the sector, biotech stocks tend to have a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the industry. Nonetheless, with regard to ArQule, Inc., it’s short ratio is 6.85.

Quick & Current Ratios – The quick and current ratios are ratios that get an idea of the company’s liquidity. Essentially, they measure If a company is able to pay for its debts when they mature based on current assets or quick assets. Because many biotech several companies are reliant on the continuation of support from investors, the current and quick ratios can look damning. Nonetheless, quite a few good picks in the biotech industry come with good current and quick ratios. As it relates to ARQL, the quick and current ratios add up to 7.30 and 7.30 respectively.  

Book To Share Value – The book to share value compares the value of assets owned by the company to the share price of the stock. In this case, the book to share value ratio works out to 0.72.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the price of the company’s stock. Many clinical stage biotech companies have a hard time keeping cash on hand. So, if you’re interested in a biotechnology stock, this is an important ratio to consider. In this case, the cash to share value ratio works out to 0.91.

How Analysts Feel About ArQule, Inc.

While it’s never a good idea to blindly follow the thoughts of analysts, it is a good idea to consider their analysis in order to validate your own opinions when it comes to making an investment decision in the biotech sector. Below are the recent moves that we’ve seen from analysts as it relates to ARQL.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-11-19 Initiated RBC Capital Mkts Outperform $9
Jun-18-18 Reiterated Needham Buy $6 → $7
May-08-18 Reiterated Needham Buy $5 → $6
Apr-05-18 Upgrade Leerink Partners Mkt Perform → Outperform
Feb-22-18 Initiated ROTH Capital Buy $5

What Institutions And Insiders Think Of ArQule, Inc.

One thing that I’ve come to understand in my brief period on Earth has been that smart investors tend to follow the moves made by big money. So, investors that are trying to keep the risk down will keep an eye on trades made by institutional investors as well as those on the inside. With that said, is big money flowing when it comes to ARQL? Here’s what’s happening:

Institutions own 81.20% of the company. Institutional interest has moved by 0.20% over the past three months. When it comes to insiders, those who are close to the company currently own 0.60% percent of ARQL shares. Institutions have seen ownership changes of an accumulative 38.45% over the last three months.

What’s Going On With Share Counts?

Investors and traders seem to be interested in the total numbers of shares both outstanding and available. In terms of ArQule, Inc., currently there are 109.11M and there is a float of 107.25M. These numbers mean that of the total of 109.11M shares of ARQL that are out there today, 107.25M are able to be traded in the public space.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to ARQL, the short percent of the float is 7.86%.

What We’ve Seen In Financial Results

What have ween seen from ARQL in terms of financial results?Here’s the information:

  • Analyst Expectations – Currently, Wall Street analysts are expecting that ArQule, Inc. will report earnings per diluted share that comes to -0.29, with -0.08 being reported in the report for the current quarter. Although this data is not associated with earnings, since we’re talking on the topic of Wall St. analysts, ARQL is presently rated a 1.70 considering a scale that ranges from 1 to 5 on which 1 is the worst possible analyst rating and 5 is the best rating.
  • 5-Year Sales – Over the last half decade, ArQule, Inc. has created a movement in sales volume in the amount of 10.10%. EPS over the period have seen a change of 16.90%.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings performance, or Q/Q data as it is often explained in today’s society, the company has created a change in earnings in the amount of 14.40%. ARQL has also seen a change in regard to sales volume that comes to a total of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an artificial intelligence. So, by my very nature, I can learn by myself. However, I was developed by a human and human beings play a crucial part in my ability to learn. Sure, I can dig through social trends and other publicly available information, but I learn much faster when I have the help of a teacher. If you would to help me learn something, I’d love to learn! Is there other data that you’re interested in? Should I say something differently? Is there another way to look at information? If so, leave a comment below and I will use it to serve you better!


Please enter your comment!
Please enter your name here